Cargando…
Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma
Tumor-targeting peptides functioned as molecular probes are essential for multi-modality imaging and molecular-targeting therapy in caner theronostics. Here, we performed a phage-displayed bio-panning to identify a specific binding peptide targeting Glypican-3 (GPC-3), a promising biomarker in hepat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212053/ https://www.ncbi.nlm.nih.gov/pubmed/34150644 http://dx.doi.org/10.3389/fonc.2021.679336 |
_version_ | 1783709600097239040 |
---|---|
author | Yan, Jiayao Yu, Xiaoxiao Chen, Xiaotong Liu, Fangcen Chen, Fangjun Ding, Naiqing Yu, Lixia Meng, Fanyan Shen, Jie Wei, Jia Liu, Baorui |
author_facet | Yan, Jiayao Yu, Xiaoxiao Chen, Xiaotong Liu, Fangcen Chen, Fangjun Ding, Naiqing Yu, Lixia Meng, Fanyan Shen, Jie Wei, Jia Liu, Baorui |
author_sort | Yan, Jiayao |
collection | PubMed |
description | Tumor-targeting peptides functioned as molecular probes are essential for multi-modality imaging and molecular-targeting therapy in caner theronostics. Here, we performed a phage-displayed bio-panning to identify a specific binding peptide targeting Glypican-3 (GPC-3), a promising biomarker in hepatocellular carcinoma (HCC). After screening in the cyclic peptide library, a candidate peptide named F3, was isolated and showed specific binding to HCC cell lines. In a bio-distribution study, higher accumulation of F3 peptide was observed in HepG-2 tumors compared to PC-3 tumors in xenograft models. After labeling with radioactive (68)Ga, the F3 peptide tracer enabled the specific detection of tumors in HCC tumor models with PET imaging. More importantly, the expression of GPC-3 in human tissue samples may be distinguished by an F3 fluorescent peptide probe indicating its potential for clinical application. This cyclic peptide targeting GPC-3 has been validated, and may be an alternative to serve as an imaging probe or a targeting domain in the drug conjugate. |
format | Online Article Text |
id | pubmed-8212053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82120532021-06-19 Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma Yan, Jiayao Yu, Xiaoxiao Chen, Xiaotong Liu, Fangcen Chen, Fangjun Ding, Naiqing Yu, Lixia Meng, Fanyan Shen, Jie Wei, Jia Liu, Baorui Front Oncol Oncology Tumor-targeting peptides functioned as molecular probes are essential for multi-modality imaging and molecular-targeting therapy in caner theronostics. Here, we performed a phage-displayed bio-panning to identify a specific binding peptide targeting Glypican-3 (GPC-3), a promising biomarker in hepatocellular carcinoma (HCC). After screening in the cyclic peptide library, a candidate peptide named F3, was isolated and showed specific binding to HCC cell lines. In a bio-distribution study, higher accumulation of F3 peptide was observed in HepG-2 tumors compared to PC-3 tumors in xenograft models. After labeling with radioactive (68)Ga, the F3 peptide tracer enabled the specific detection of tumors in HCC tumor models with PET imaging. More importantly, the expression of GPC-3 in human tissue samples may be distinguished by an F3 fluorescent peptide probe indicating its potential for clinical application. This cyclic peptide targeting GPC-3 has been validated, and may be an alternative to serve as an imaging probe or a targeting domain in the drug conjugate. Frontiers Media S.A. 2021-06-04 /pmc/articles/PMC8212053/ /pubmed/34150644 http://dx.doi.org/10.3389/fonc.2021.679336 Text en Copyright © 2021 Yan, Yu, Chen, Liu, Chen, Ding, Yu, Meng, Shen, Wei and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Yan, Jiayao Yu, Xiaoxiao Chen, Xiaotong Liu, Fangcen Chen, Fangjun Ding, Naiqing Yu, Lixia Meng, Fanyan Shen, Jie Wei, Jia Liu, Baorui Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma |
title | Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma |
title_full | Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma |
title_fullStr | Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma |
title_full_unstemmed | Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma |
title_short | Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma |
title_sort | identification of a glypican-3 binding peptide from a phage-displayed peptide library for pet imaging of hepatocellular carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212053/ https://www.ncbi.nlm.nih.gov/pubmed/34150644 http://dx.doi.org/10.3389/fonc.2021.679336 |
work_keys_str_mv | AT yanjiayao identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT yuxiaoxiao identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT chenxiaotong identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT liufangcen identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT chenfangjun identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT dingnaiqing identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT yulixia identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT mengfanyan identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT shenjie identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT weijia identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma AT liubaorui identificationofaglypican3bindingpeptidefromaphagedisplayedpeptidelibraryforpetimagingofhepatocellularcarcinoma |